Approches basées sur CRISPR/Cas9 pour la maladie de Huntington: Du laboratoire à la clinique
CRISPR/Cas9 technology offers promising avenues for treating Huntington’la maladie, a debilitating neurodegenerative disorder. This article explores the latest advancements in CRISPR/Cas9-based approaches, examining their potential for clinical translation and the challenges that need to be overcome.